65,437 trials
Cryptococcal Meningitis · HIV Infections
Primary: Number of Participants Who Discontinued Study-provided High Dose Fluconazole or Ampho B — 14; 11; 11; 6 Participants — p=0.0012
Wet Macular Degeneration
Primary: Mean Change From Baseline in BCVA at Week 52 — 9.0; 8.4 letters
Bipolar Disorder · Bipolar Depression · Manic Depression
Primary: Change in GLX (Glutamate + Glutamine) to Creatine (Cr) Ratio in the Anterior Cingulate Cortex of the Brain, as Measured With Proton-1 Magnetic Resonance Spectroscopy…
Clostridium Difficile · Clostridium Infections
Primary: Percentage of Patients With Clostridium Difficile Infection at 4- Weeks of Follow-up. — 2; 7 Participants — p=0.045
Infraorbital Hollows
Primary: The Primary Objective of This Study is to Determine the Efficacy and Longevity of the Use of Restylane® and Perlane® in Combination for the Rejuvenation of the…
Cachexia · Squamous Cell Carcinoma
Primary: Change in Total Lean Body Mass as Measured by Dual Energy X-ray Absorptiometry (DEXA) From Baseline to 7 Weeks. — -3.31; 1.42 Percent change
Alcohol Drinking
Primary: Number of Drinks Consumed During an Ad-libitum Drinking Period — 1.59; 1.64 drinks
Estrogen Receptor-negative Breast Cancer · Estrogen Receptor-positive Breast Cancer · HER2-positive Breast Cancer
Primary: Combined Rate of Microscopic pCR and Macroscopic Pathologic Complete Response (mCR) — 29 Participants
Chronic Obstructive Pulmonary Disease
Primary: Trough FEV1 (Change From Baseline) — -0.093; 0.0114; 0.0447; 0.0542 liters — p=0.1257
Relapsed/Refractory Aggressive B-cell Lymphomas
Primary: Maximum Tolerated Dose (MTD) of MEDI-551 — NA; NA mg/kg
Mild to Severe Alzheimer's Disease
Primary: Mini Mental State Examination (MMSE) Total Scores by Visit — 18.7; 20.8; 20.5; 20.5 Scores on a scale
Arterial Occlusion · Angina Pectoris · Cardiovascular Diseases
Primary: Time to Hemostasis Using the Hemostasis Management System (HMS) — 160; 42.95 minutes
Pelvic Pain
Primary: Change From Baseline in Pain on the Visual Analog Scale (VAS) at Week 12 — -8.5; -7.4 units on a scale — p=0.8979
Abscess · Fracture
Primary: Median Effective Dose (ED50) and ED95 of Rapidly Administered Ketamine — 0.7; 0.5; 0.6; 0.9 mg/kg of ketamine dose
Postoperative Pain
Primary: NRS (Numerical Rating Scale) — 3.5; 3.4; 5.4; 5.5 units on a scale — p=0.89